Related Experiment Video
Updated: Jun 24, 2026

14:04
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Surveillance for severe community-associated methicillin-resistant Staphylococcus aureus infection
P Wiersma1, M Tobin D'Angelo, W R Daley
1Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA. Petra.wiersma@gmail.com
Epidemiology and Infection
|April 16, 2009
Summary
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) causes severe infections. Pneumonia and invasive CA-MRSA disease are significantly more deadly than skin infections.
Area of Science:
- Infectious Diseases
- Epidemiology
- Public Health
Background:
- Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is a growing cause of severe infections in the US.
- CA-MRSA infections occur in individuals without traditional risk factors.
Purpose of the Study:
- To describe the epidemiology of severe CA-MRSA disease in Georgia, USA.
- To analyze the risk of death associated with different CA-MRSA clinical syndromes.
Main Methods:
- Retrospective analysis of 1670 severe CA-MRSA cases reported from 2005-2007.
- Comparison of case-fatality rates across pneumonia, invasive disease, and skin and soft-tissue infections (SSTIs).
- Risk analysis using risk ratios and odds ratios, controlling for age and other clinical syndromes.
Main Results:
- The overall case-fatality rate for severe CA-MRSA was 3.4%.
- CA-MRSA pneumonia and invasive disease were significantly more lethal than SSTIs (RR 16.69 and 13.98, respectively).
- Pneumonia presented the highest odds of death (OR 11.34) when controlling for other factors.
Conclusions:
- Severe CA-MRSA syndromes, particularly pneumonia, carry a substantial risk of mortality.
- Draining lesions without medical care and preceding influenza-like illness may be risk factors for severe CA-MRSA SSTI and pneumonia.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Staphylococcal Skin Infections
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...